These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 1385275
1. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report. Garavelli PL. Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275 [No Abstract] [Full Text] [Related]
2. Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia. Clumeck N, Wit SD, Hermans P, Franchioly P, Sommereijns B. J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():353-6. PubMed ID: 1284305 [No Abstract] [Full Text] [Related]
3. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study. van der Wouw PA, van Leeuwen R, van Oers RH, Lange JM, Danner SA. Br J Haematol; 1991 Jul; 78(3):319-24. PubMed ID: 1714756 [Abstract] [Full Text] [Related]
4. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias]. Garavelli PL, Berti P. Recenti Prog Med; 1993 Jul; 84(7-8):526-30. PubMed ID: 8356307 [Abstract] [Full Text] [Related]
5. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. Levine JD, Allan JD, Tessitore JH, Falcone N, Galasso F, Israel RJ, Groopman JE. Blood; 1991 Dec 15; 78(12):3148-54. PubMed ID: 1742482 [Abstract] [Full Text] [Related]
6. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. Kimura S, Matsuda J, Ikematsu S, Miyazono K, Ito A, Nakahata T, Minamitani M, Shimada K, Shiokawa Y, Takaku F. AIDS; 1990 Dec 15; 4(12):1251-5. PubMed ID: 1708265 [Abstract] [Full Text] [Related]
7. [Tongue ulcer in azidothymidine-induced neutropenia. Rapid increase in neutrophils and healing of the ulcer by substitution of recombinant human granulocyte colony stimulating factor (rhG-CSF)]. Schwander S, Kern P. Med Klin (Munich); 1993 Feb 15; 88(2):60-2. PubMed ID: 7680750 [No Abstract] [Full Text] [Related]
8. [Granulocyte colony-stimulating factor in a patient with toxic neutropenia and acquired immunodeficiency syndrome]. Alba D, Ripoll MM, Rodríguez MD, Molina F. Med Clin (Barc); 1992 Jul 04; 99(6):235-6. PubMed ID: 1380622 [No Abstract] [Full Text] [Related]
9. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA. Blood; 1991 May 15; 77(10):2109-17. PubMed ID: 1709368 [Abstract] [Full Text] [Related]
10. No antibodies to granulocyte macrophage colony-stimulating factor with prolonged use in AIDS. Scadden DT, Agosti J. AIDS; 1993 Mar 15; 7(3):438. PubMed ID: 8471211 [No Abstract] [Full Text] [Related]
11. [Current developments in the treatment of AIDS]. Mulder JW. Ned Tijdschr Geneeskd; 1989 Aug 19; 133(33):1664-6. PubMed ID: 2477718 [No Abstract] [Full Text] [Related]
12. The use of growth hematopoietic factors in AIDS. Groopman JE. Pathol Biol (Paris); 1992 Nov 19; 39(9):874-5. PubMed ID: 1371606 [No Abstract] [Full Text] [Related]
13. [Granulocyte colony-stimulating factor in the treatment of neutropenia associated with HIV infection]. Moreno García M, Fernández González F, Fernández Rodríguez E, Portús de Marco MV. Med Clin (Barc); 1996 Jul 06; 107(6):237-8. PubMed ID: 8755453 [No Abstract] [Full Text] [Related]
14. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study. Stambuk D, Youle M, Hawkins D, Farthing C, Shanson D, Farmer R, Lawrence A, Gazzard B. Q J Med; 1989 Feb 06; 70(262):161-74. PubMed ID: 2512592 [Abstract] [Full Text] [Related]
15. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias]. Martínez Ruiz M, Llobell Segui G, Peralba Vaño JI, Toral Revuelta JR, Mellado del Rey F, González de Aledo GB. An Med Interna; 1992 Dec 06; 9(12):624. PubMed ID: 1283082 [No Abstract] [Full Text] [Related]
16. [Treatment of neutropenia in HIV infection with hematopoietic growth factors]. Moreno García M, Fernández González F. Rev Clin Esp; 1996 Apr 06; 196(4):248-54. PubMed ID: 8701065 [No Abstract] [Full Text] [Related]
17. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. Wong SF, Chan HO. Pharmacotherapy; 2005 Mar 06; 25(3):372-8. PubMed ID: 15843284 [Abstract] [Full Text] [Related]
18. Hematologic toxicity of zidovudine in HIV-infected patients. Brogan KL, Zell SC. Am Fam Physician; 1990 May 06; 41(5):1521-8. PubMed ID: 1692180 [Abstract] [Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection. Hewitt RG, Morse GD. Pharmacotherapy; 1992 May 06; 12(6):455-61. PubMed ID: 1492010 [Abstract] [Full Text] [Related]
20. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)]. Med Clin (Barc); 1994 May 21; 102(19):747-50. PubMed ID: 7518884 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]